2.要約中間連結財務諸表及び主な注記
(1)要約中間連結財政状態計算書
| | | (単位:百万円) |
| 前連結会計年度 (2024年3月31日) | | 当中間連結会計期間 (2024年9月30日) |
資産 | | | |
流動資産 | | | |
現金及び現金同等物 | 47,044 | | 32,969 |
営業債権 | 73,802 | | 63,711 |
棚卸資産 | 52,651 | | 54,737 |
その他の金融資産 | 4,775 | | 4,152 |
その他の流動資産 | 9,575 | | 9,987 |
流動資産合計 | 187,849 | | 165,557 |
非流動資産 | | | |
有形固定資産 | 49,708 | | 48,769 |
のれん | 208,719 | | 202,567 |
無形資産 | 91,388 | | 83,749 |
持分法で会計処理されている投資 | 2,188 | | 1,936 |
その他の金融資産 | 13,987 | | 10,919 |
繰延税金資産 | 7,058 | | 10,248 |
その他の非流動資産 | 3,426 | | 1,687 |
非流動資産合計 | 376,477 | | 359,878 |
資産合計 | 564,327 | | 525,436 |
| | | (単位:百万円) |
| 前連結会計年度 (2024年3月31日) | | 当中間連結会計期間 (2024年9月30日) |
負債及び資本 | | | |
負債 | | | |
流動負債 | | | |
営業債務及びその他の債務 | 69,881 | | 62,316 |
借入金 | 36,922 | | 34,944 |
未払法人所得税等 | 2,311 | | 5,565 |
引当金 | 6,587 | | 6,189 |
その他の金融負債 | 6,251 | | 5,587 |
その他の流動負債 | 25,445 | | 19,917 |
流動負債合計 | 147,400 | | 134,520 |
非流動負債 | | | |
営業債務及びその他の債務 | 847 | | 661 |
借入金 | 248,123 | | 233,169 |
退職給付に係る負債 | 5,709 | | 6,447 |
引当金 | 3,431 | | 3,733 |
その他の金融負債 | 9,200 | | 8,913 |
繰延税金負債 | 9,109 | | 9,350 |
その他の非流動負債 | 1,340 | | 1,249 |
非流動負債合計 | 277,763 | | 263,526 |
負債合計 | 425,163 | | 398,046 |
資本 | | | |
資本金 | 48,423 | | 48,522 |
資本剰余金 | 41,797 | | 41,802 |
利益剰余金 | △2,773 | | △1,841 |
自己株式 | △568 | | △568 |
その他の資本の構成要素 | 52,635 | | 39,887 |
親会社の所有者に帰属する持分合計 | 139,515 | | 127,803 |
非支配持分 | △351 | | △413 |
資本合計 | 139,163 | | 127,389 |
負債及び資本合計 | 564,327 | | 525,436 |
E3697665230PHCホールディングス株式会社PHC Holdings Corporation四半期第7号参考様式 [IFRS](連結)(一般2Q)IFRStrueCTE2024-04-012024-09-30Q22025-03-312023-04-012023-09-302024-03-311falsefalsefalse652302024-04-012024-09-30jpcrp_cor:ReportableSegmentsMember652302024-04-012024-09-30tse-scediffr-65230:DiabetesManagementReportableSegmentMember652302024-04-012024-09-30tse-scediffr-65230:HealthcareSolutionsReportableSegmentMember652302024-04-012024-09-30tse-scediffr-65230:DiagnosticsAndLifeSciencesReportableSegmentMember652302024-04-012024-09-30jpcrp_cor:ReconcilingItemsMember652302023-04-012023-09-30jpcrp_cor:ReportableSegmentsMember652302023-04-012023-09-30tse-scediffr-65230:DiabetesManagementReportableSegmentMember652302023-04-012023-09-30tse-scediffr-65230:HealthcareSolutionsReportableSegmentMember652302023-04-012023-09-30tse-scediffr-65230:DiagnosticsAndLifeSciencesReportableSegmentMember652302023-04-012023-09-30jpcrp_cor:ReconcilingItemsMember652302024-09-30jpigp_cor:NonControllingInterestsIFRSMember652302024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember652302024-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302024-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302024-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302024-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302024-09-30jpigp_cor:TreasurySharesIFRSMember652302024-09-30jpigp_cor:RetainedEarningsIFRSMember652302024-09-30jpigp_cor:CapitalSurplusIFRSMember652302024-09-30jpigp_cor:ShareCapitalIFRSMember652302024-04-012024-09-30jpigp_cor:NonControllingInterestsIFRSMember652302024-04-012024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302024-04-012024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember652302024-04-012024-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302024-04-012024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302024-04-012024-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302024-04-012024-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302024-04-012024-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302024-04-012024-09-30jpigp_cor:TreasurySharesIFRSMember652302024-04-012024-09-30jpigp_cor:RetainedEarningsIFRSMember652302024-04-012024-09-30jpigp_cor:CapitalSurplusIFRSMember652302024-04-012024-09-30jpigp_cor:ShareCapitalIFRSMember652302024-03-31jpigp_cor:NonControllingInterestsIFRSMember652302024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302024-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302024-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302024-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302024-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302024-03-31jpigp_cor:TreasurySharesIFRSMember652302024-03-31jpigp_cor:RetainedEarningsIFRSMember652302024-03-31jpigp_cor:CapitalSurplusIFRSMember652302024-03-31jpigp_cor:ShareCapitalIFRSMember652302023-09-30jpigp_cor:NonControllingInterestsIFRSMember652302023-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302023-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember652302023-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302023-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302023-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302023-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302023-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302023-09-30jpigp_cor:TreasurySharesIFRSMember652302023-09-30jpigp_cor:RetainedEarningsIFRSMember652302023-09-30jpigp_cor:CapitalSurplusIFRSMember652302023-09-30jpigp_cor:ShareCapitalIFRSMember652302023-04-012023-09-30jpigp_cor:NonControllingInterestsIFRSMember652302023-04-012023-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302023-04-012023-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember652302023-04-012023-09-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302023-04-012023-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302023-04-012023-09-30jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302023-04-012023-09-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302023-04-012023-09-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302023-04-012023-09-30jpigp_cor:TreasurySharesIFRSMember652302023-04-012023-09-30jpigp_cor:RetainedEarningsIFRSMember652302023-04-012023-09-30jpigp_cor:CapitalSurplusIFRSMember652302023-04-012023-09-30jpigp_cor:ShareCapitalIFRSMember652302023-03-31jpigp_cor:NonControllingInterestsIFRSMember652302023-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember652302023-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember652302023-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember652302023-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember652302023-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember652302023-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember652302023-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember652302023-03-31jpigp_cor:TreasurySharesIFRSMember652302023-03-31jpigp_cor:RetainedEarningsIFRSMember652302023-03-31jpigp_cor:CapitalSurplusIFRSMember652302023-03-31jpigp_cor:ShareCapitalIFRSMember652302024-11-13652302024-09-30652302024-04-012024-09-30652302023-09-30652302023-04-012023-09-30652302024-03-31652302023-03-31iso4217:JPYxbrli:sharesxbrli:pureiso4217:JPY